Patents Assigned to Telios Pharma, Inc.
  • Methods of Treating Splenomegaly
    Publication number: 20240024314
    Abstract: Therapeutic methods and pharmaceutical compositions for treating splenomegaly in a human subject are described. In certain embodiments, the invention includes therapeutic methods of treating splenomegaly using a BTK inhibitor.
    Type: Application
    Filed: January 8, 2021
    Publication date: January 25, 2024
    Applicant: Telios Pharma, Inc.
    Inventor: Wayne Philip Rothbaum
  • METHODS AND COMPOSITIONS FOR TREATING AN OPHTHALMIC CONDITION
    Publication number: 20240000782
    Abstract: Therapeutic methods and pharmaceutical compositions for treating an ophthalmic condition including dry eye syndrome and uveitis in a human subject are described. In certain embodiments, the disclosure includes therapeutic methods using a BTK inhibitor.
    Type: Application
    Filed: December 2, 2021
    Publication date: January 4, 2024
    Applicant: Telios Pharma, Inc.
    Inventors: Wayne Philip Rothbaum, Michael Weiser
  • Methods of treating splenomegaly
    Patent number: 11642343
    Abstract: Therapeutic methods and pharmaceutical compositions for treating splenomegaly in a human subject are described. In certain embodiments, the invention includes therapeutic methods of treating splenomegaly using a BTK inhibitor.
    Type: Grant
    Filed: December 30, 2021
    Date of Patent: May 9, 2023
    Assignee: Telios Pharma, Inc.
    Inventor: Wayne Philip Rothbaum
  • METHODS OF TREATING SPLENOMEGALY
    Publication number: 20220184069
    Abstract: Therapeutic methods and pharmaceutical compositions for treating splenomegaly in a human subject are described. In certain embodiments, the invention includes therapeutic methods of treating splenomegaly using a BTK inhibitor.
    Type: Application
    Filed: December 30, 2021
    Publication date: June 16, 2022
    Applicant: Telios Pharma, Inc.
    Inventor: Wayne Philip Rothbaum